HOME >> MEDICINE >> NEWS
Diets with group support may help keep weight off longer

Commercial diets are a useful way to lose weight. And those based on group support seem to fare better at keeping the weight off in the long term, finds a study in this week's BMJ.

Please note, this paper was published on bmj.com on 23 May 2006, so is not under embargo.

Researchers compared the effectiveness of four popular commercial weight loss programmes with a control group. The study was sponsored by the BBC as part of its reality TV series, BBC Diet Trials.

The diets were the Slim-Fast Plan (a meal replacement approach), Weight Watchers pure points programme (an energy controlled diet with weekly group meetings), Dr Atkins' new diet revolution (a self-monitored low carbohydrate eating plan), and Rosemary Conley's eat yourself slim diet and fitness plan (a low fat diet and weekly exercise class). The control group was asked to maintain their current diet and exercise pattern.

Weight and body fat changes were monitored over six months and dieting behaviour was checked again at 12 months.

After six months, all diets resulted in significant loss of body fat and weight compared to the control group. Average weight loss was 5.9 kg and average fat loss was 4.4. kg (5-10% of body weight). The Atkins diet resulted in significantly higher weight loss during the first four weeks, but by the end, was no more or less effective than the other diets.

There were no significant differences in cardiac risk factors between the diet groups and the control group. The Atkins diet did not lead to substantial increases in cholesterol levels.

At 12 months, 158 participants (54% of the original sample) returned data. Only 58 (45%) were still keeping to their allocated diets (nine to Atkins, 20 to Weight Watchers, nine to Slim-Fast, 20 to Rosemary Conley). More participants in the unsupported programmes (Atkins diet and Slim-Fast) withdrew from the study than in the supported group based programmes, and weight rebound after the in
'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-207-383-6529
BMJ-British Medical Journal
1-Jun-2006


Page: 1 2

Related medicine news :

1. Diets high in choline may increase risk for colorectal polyps
2. Diets rich in calcium and vitamin D may decrease risk of PMS
3. International journal group updates guidelines on registration of clinical trials
4. New research disproves belief that group psychotherapy extends the lives of cancer patients
5. Health gap between social groups widens in later life
6. INTERMACS group reveals recent successes to international transplant community
7. Risk of birth complications varies between racial groups
8. Targeted melanoma education of high risk groups improves screening
9. Giving African surgeons online health information; cancer in minority groups
10. Tuberculosis must be tackled among socially excluded groups
11. Patients groups should declare pharmaceutical company funding

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Diets with group support may help keep weight off longer

(Date:5/20/2013)... Heritage Woods of Gurnee , a ... is hosting Breakfast and Bingo at 8:30 a.m. on ... at 3775 Grand Ave. in Gurnee, Illinois, serves older ... need some help to maintain their independence. , "Come ... bingo," says Tammy Temaner-Rosas, Director of Marketing for Heritage ...
(Date:5/20/2013)... MN (PRWEB) May 20, 2013 When a ... bed is only part of the process. Much of the ... the internet involves not knowing what to expect. Best ... advice consumers can use to ensure their purchase proves smooth. ... You Buy a Mattress Online ”, readers find helpful tips ...
(Date:5/20/2013)... 2013 Fastcare Miami Beach clinic ... within its first symptoms, as if not treated, it may ... serious infection. Although a urinary tract infection in itself is ... serious kidney infection called pyelonephritis. Women seem to have many ... to the same percentage as women after the age of ...
(Date:5/20/2013)... 20, 2013 Eben Pagan's ... the public creating a frenzy among business owners ... elite business training. WealthSpringMarketing.com's Tiffany Hendricks has published ... an exclusive bonus. , "Eben Pagan is a ... training to individuals serious about success," reports Hendricks. ...
(Date:5/20/2013)... May 20, 2013 Leading facial plastic surgeon ... recognized as a “Top Doc” in the field of Otolaryngology ... , The Palm Beacher magazine, one of Palm Beach ... Docs” in the May/June 2013 issue, including 70 of the ... and dining, events, things to do, health and fitness, people ...
Breaking Medicine News(10 mins):Health News:Heritage Woods of Gurnee Affordable Assisted Living Community to Host Breakfast and Bingo 2Health News:See What to Expect When You Buy a Mattress Online With Latest Guide From Best Mattress Online 2Health News:Fastcare Advises on How to Prevent a UTI 2Health News:Eben Pagan's Accelerate: Review and Bonus Released By WealthSpringMarketing.com 2Health News:Dr. Schwartz Named “Top Doc” by The Palm Beacher Magazine 2
(Date:5/20/2013)... ATLANTA , May 20, 2013  Atlantic ... developed and is commercializing a unique technology to ... founder and President, Anthony Soscia ... the Atlanta Business Chronicle ,s Health-Care Heroes ... Atlanta Business Chronicle to honor individuals and ...
(Date:5/20/2013)... May 20, 2013 Enrollment of patients with ... 2b dose-finding clinical trial of product candidate NewMet ... treatment for Type 2 diabetes. Elcelyx expects to complete ... in June. Results of the trial,s primary endpoint of ... summer, and the read-out for long-term glucose lowering and ...
(Date:5/20/2013)... Md. , May 20, 2013  Neuralstem, Inc. ... Feldman , MD, PhD, principal investigator, presented updated ... stem cell (NSI-566) trial in the treatment of amyotrophic ... ,s disease) at the neuro diabetes special medical symposium ... In a talk called "Recent Therapeutic Advances in Stem ...
Breaking Medicine Technology:Atlantic Pharmaceuticals President Named Health Care Hero Finalist in Atlanta Business Chronicle for Drug Abuse Deterrent Technology 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 4Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 2Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 3Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 4
Cached News: